Back

IBB Stock

Live symbol workspace

IBB market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $169.37
Trend Flat
Sentiment Neutral

Price Chart

📈
Loading chart for IBB...
Powered by TradingView
{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support
$160.90
Resistance
$177.84

Volume & Momentum

Volume
Weak
0.8x avg
Momentum
0%
Weak

Technical Context

Current price
$169.37
RSI context
50

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%
— 0.0 pts vs previous week
Avg confidence across 11 calls in the last 7 days

What sources say

Bullish 1 article
Hedge Fund Healthcare Bets Approach Five-Year High

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

IBB News Intelligence (11 articles)

AI-curated news influencing IBB price, sentiment, and trend

Explore All IBB News with AI Analysis
Economy
3 weeks, 3 days ago

Why Bristol Myers Squibb Stock Topped the Market on Thursday

It notched convincing beats on analyst estimates with its second-quarter performance.

Impact on IBB: Neutral market sentiment indicated
Analysis of stock market developments showing neutral sentiment. Medium (50%)
View full analysis →
Yahoo Finance 50% confidence
Economy
3 weeks, 6 days ago

Hedge Fund Healthcare Bets Approach Five-Year High

Specialist funds returned nearly 40% as AI drug discovery and deal activity attracted additional capital.

Impact on IBB: The increased investment in healthcare is expected to positively impact healthcare stocks, …
Hedge fund investments in the healthcare sector have reached a nearly five-year high, driven by … High (80%)
View full analysis →
Yahoo Finance 80% confidence
Economy
1 month ago

Blue Owl-Backed Latigo Files for IPO, Adding to Biotech Pipeline

Latigo Biotherapeutics Inc. filed for an initial public offering, joining a growing list of biotechnology firms considering going public as …

Impact on IBB: The news may lead to a short-term boost in biotech stocks, particularly …
Latigo Biotherapeutics Inc. has filed for an initial public offering, adding to the growing pipeline … High (70%)
View full analysis →
Bloomberg 70% confidence
Economy
1 month, 2 weeks ago

IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?

Established pharmaceutical giants have delivered lower volatility and higher income than clinical-stage biotech exposure over the past five years.

Impact on IBB: May pressure downward momentum
Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)
View full analysis →
Yahoo Finance 60% confidence
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis
Open article